宫颈癌根治性子宫切除术后根据排尿试验方法评估术后尿潴留
该回顾性分析纳入2014年1月至2023年2月因FIGO 2018 IA2-IB2期宫颈癌行根治性子宫切除术的115例患者,比较定时、自动充盈和回填三种术后排尿试验方法下的尿潴留发生率及围手术期结局。结果显示44.3%患者发生术后尿潴留,不同排尿试验方法间无差异(p=0.17);回填排尿试验组尿潴留更可能在7天(p=0.012)和30天(p=0.01)内缓解,多因素模型中回填排尿试验与30天无尿潴留相关(aOR 15.1;95%CI 1.5-154.9)。
要点
- 根治性子宫切除术后尿潴留发生率为44.3%,不同排尿试验方法间无显著差异(p=0.17)。
- 回填排尿试验组尿潴留更可能在术后7天(p=0.012)和30天(p=0.01)内缓解。
- 多因素模型中,回填排尿试验与30天无尿潴留相关(aOR 15.1;95%CI 1.5-154.9)。
核心结论
- 根治性子宫切除术后尿潴留发生率不因术后排尿试验方法不同而存在差异。
- 根治性子宫切除术后采用回填排尿试验可能提高术后尿潴留的缓解率。
研究设计与样本
- 回顾性分析2014年1月至2023年2月因明显早期宫颈癌(FIGO 2018 IA2-IB2期)行根治性子宫切除术的患者。
- 共纳入115例患者,其中48例(41.8%)完成定时排尿试验,40例(34.7%)完成自动充盈排尿试验,27例(23.5%)完成回填排尿试验。
- 采用多因素logistic回归分析排尿试验类型与术后30天内无尿潴留的关联。
主要发现
- 44.3%的患者发生术后尿潴留,不同排尿试验方法间无差异(p=0.17)。
- 回填排尿试验组患者尿潴留更可能在7天(p=0.012)和30天(p=0.01)内缓解,与其他试验相比。
- 多因素模型中,与其他试验相比,回填排尿试验与30天无尿潴留相关(aOR 15.1;95% C.I. 1.5-154.9)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Radical hysterectomy is the standard of care for management of early-stage cervical cancer and is associated with postoperative urinary retention. No clear consensus exists regarding optimal voiding trial methodology for mitigating postoperative urinary retention. Our objective was to evaluate the association between type of postoperative voiding trial and risk of urinary retention after radical hysterectomy for cervical cancer. METHODS: We conducted a retrospective analysis of patients undergoing radical hysterectomy for apparent early-stage cervical cancer (FIGO 2018 Stage IA2-IB2) between January 2014 and February 2023. We compared incidence of urinary retention and perioperative outcomes based on method of postoperative voiding trial (timed, autofill, or backfill). Multivariate logistic regression was used to determine association of type of void trial with absence of urinary retention within 30 days postoperatively. RESULTS: Of the 115 patients identified, 48 (41.8%) patients completed a timed void trial, 40 (34.7%) an autofill void trial, and 27 (23.5%) a backfill void trial. 44.3% of patients developed postoperative urinary retention with no differences based on void trial (p = 0.17). Urinary retention was more likely to resolve by 7 (p = 0.012) and 30 days (p = 0.01) for patients undergoing backfill voiding trials, compared to other trials. In multivariate models, backfill void trial was associated with absence of 30-day urinary retention, compared to other trials (aOR 15.1; 95% C.I. 1.5-154.9). CONCLUSIONS: Rates of urinary retention following radical hysterectomy do not differ based on postoperative void trial methodology. A backfill void trial following radical hysterectomy may lead to increased rates of resolution of postoperative urinary retention.
引用
- Wagar MK, Patel UJ, Bharucha K, et al. Postoperative urinary retention by void trial methodology following radical hysterectomy for cervical cancer. Gynecol Oncol. 2024. PMID: 39167999. doi:10.1016/j.ygyno.2024.08.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。